Loading patent…
AssigneeEnterome S.A.
InventorsLaurent CHENE, Alessandra CERVINO, Francesco STROZZI, Celia MENDEZ, Christophe BONNY
Estimating the term…
The present invention relates to cancer immunotherapy, in particular to sequence variants of tumor-related antigenic epitope sequences. Namely, the present invention provides a method for identification of microbiota sequence variants of tumor-related antigenic epitope sequences. Such microbiota sequence variants are useful for the preparation of anticancer medicaments, since they differ from self-antigens and, thus, they may elicit a strong immune response. Accordingly, medicaments comprising microbiota sequence variants, methods of preparing such medicaments and uses of such medicaments are provided.
A method for identification of a human microbiota peptide sequence variant of a human tumor-related antigenic epitope sequence, the method comprising the following steps:
-5. (canceled)
(canceled)
(canceled)
(canceled)
-23. (canceled)
A microbiota sequence variant of a human tumor-related antigenic epitope sequence.
(canceled)
-34. (canceled)
-42. (canceled)
-47. (canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.